0

Journal Articles

in Alzheimer Disease
 21-40 of 92 Articles
Editorial |  November 03, 2010
Treatment of Alzheimer Disease and Prognosis of Dementia:  Time to Translate Research to Results
Kristine Yaffe, MD
JAMA. 2010;304(17):1952-1953. doi:10.1001/jama.2010.1625.
Medical News and Perspectives |  November 03, 2010
Are CSF Biomarkers Ready for Prime Time as Diagnostics for Alzheimer Disease?
Rebecca Voelker
JAMA. 2010;304(17):1887. doi:10.1001/jama.2010.1587.
Original Contribution |  November 03, 2010 FREE
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease:  A Randomized Trial
Joseph F. Quinn, MD; Rema Raman, PhD; Ronald G. Thomas, PhD; et al.
JAMA. 2010;304(17):1903-1911. doi:10.1001/jama.2010.1510.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  October 06, 2010
New Plaque-Boosting Protein a Possible Alzheimer Target
Rebecca Voelker
JAMA. 2010;304(13):1431. doi:10.1001/jama.2010.1390.
Editorial |  May 12, 2010
Reaching the Limits of Genome-wide Significance in Alzheimer Disease:  Back to the Environment
Nancy L. Pedersen, PhD
JAMA. 2010;303(18):1864-1865. doi:10.1001/jama.2010.609.
Original Contribution |  May 12, 2010 FREE
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Sudha Seshadri, MD; Annette L. Fitzpatrick, PhD; M. Arfan Ikram, MD, PhD; et al.
JAMA. 2010;303(18):1832-1840. doi:10.1001/jama.2010.574.
INCLUDES: , Supplemental Content
Original Contribution |  December 16, 2009 FREE
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease:  A Randomized Controlled Trial
Robert C. Green, MD, MPH; Lon S. Schneider, MD; David A. Amato, PhD; et al.
JAMA. 2009;302(23):2557-2564. doi:10.1001/jama.2009.1866.
INCLUDES: , Supplemental Content
Original Contribution |  December 16, 2009 FREE
Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
Wolfgang Lieb, MD; Alexa S. Beiser, PhD; Ramachandran S. Vasan, MD; et al.
JAMA. 2009;302(23):2565-2572. doi:10.1001/jama.2009.1836.
INCLUDES: , Supplemental Content
Editorial |  July 22, 2009
Use of Alzheimer Disease Biomarkers:  Potentially Yes for Clinical Trials but Not Yet for Clinical Practice
Ronald C. Petersen, PhD, MD; John Q. Trojanowski, MD, PhD
JAMA. 2009;302(4):436-437. doi:10.1001/jama.2009.1073.
Original Contribution |  July 22, 2009 FREE
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson, MD; Henrik Zetterberg, MD, PhD; Oskar Hansson, MD, PhD; et al.
JAMA. 2009;302(4):385-393. doi:10.1001/jama.2009.1064.
INCLUDES: , Supplemental Content
Medical News & Perspectives |  June 17, 2009
Therapeutic Environmental Design Aims to Help Patients With Alzheimer Disease
M. J. Friedrich
JAMA. 2009;301(23):2430. doi:10.1001/jama.2009.809.
Medical News & Perspectives |  December 10, 2008
Alzheimer Researchers Focus Efforts on Early Development and Earlier Detection
M. J. Friedrich
JAMA. 2008;300(22):2595-2597. doi:10.1001/jama.2008.722.
Editorial |  November 19, 2008
Ginkgo biloba Extract and Preventing Alzheimer Disease
Lon S. Schneider, MD
JAMA. 2008;300(19):2306-2308. doi:10.1001/jama.2008.675.
The World in Medicine |  November 19, 2008
Alzheimer Disease Protection
Joan Stephenson, PhD
JAMA. 2008;300(19):2239. doi:10.1001/jama.300.19.2239-c.
Lab Reports |  November 05, 2008
Alzheimer Disease Gene
Tracy Hampton, PhD
JAMA. 2008;300(17):1989. doi:10.1001/jama.2008.531.
Original Contribution |  October 15, 2008 FREE
High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease:  A Randomized Controlled Trial
Paul S. Aisen, MD; Lon S. Schneider, MD, MS; Mary Sano, PhD; et al.
JAMA. 2008;300(15):1774-1783. doi:10.1001/jama.300.15.1774.
Medical News & Perspectives |  September 17, 2008
Studies Probe Potential of Experimental Therapies for Alzheimer Disease
Tracy Hampton, PhD
JAMA. 2008;300(11):1287-1289. doi:10.1001/jama.300.11.1287.
Editorial |  September 03, 2008
Physical Activity for Older Adults at Risk for Alzheimer Disease
Eric B. Larson, MD, MPH
JAMA. 2008;300(9):1077-1079. doi:10.1001/jama.300.9.1077.
Original Contribution |  September 03, 2008 FREE
Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease:  A Randomized Trial
Nicola T. Lautenschlager, MD; Kay L. Cox, PhD; Leon Flicker, MBBS, PhD; et al.
JAMA. 2008;300(9):1027-1037. doi:10.1001/jama.300.9.1027.
The World in Medicine |  August 20, 2008
Drugs’ Adverse Effects
Joan Stephenson, PhD
JAMA. 2008;300(7):782. doi:10.1001/jama.300.7.782-c.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  March 11, 2013
Sleep Quality and Preclinical Alzheimer Disease
Yo-El S. Ju, MD; Jennifer S. McLeland, MSW, MA; Cristina D. Toedebusch, BS; et al.
JAMA Neurology
Viewpoint  |  April 29, 2013
DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease
Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
JAMA Neurology
Observation  |  April 22, 2013
Progranulin Mutations as Risk Factors for Alzheimer Disease
David C. Perry, MD; Manja Lehmann, PhD; Jennifer S. Yokoyama, PhD; et al.
JAMA Neurology
Original Contribution  |  April 15, 2013
C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Matthew Harms, MD; Bruno A. Benitez, MD; Nigel Cairns, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems